US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

9.83

+1.4717.58%

Post-market: 9.850.0200+0.20%19:56 EDT

Volume:2.84M

Turnover:27.53M

Market Cap:316.48M

PE:-5.53

High:10.43

Open:8.37

Low:8.37

Close:8.36

Loading ...

Overview Company News Filings

Sagimet Biosciences Elects New Directors at Annual Meeting

Sagimet Biosciences Inc. Announces Revised Executive Compensation Agreements with Enhanced Severance Provisions

Sagimet Biosciences to host KOL event on denifanstat results

Sagimet Biosciences Announces Positive Phase 3 Trial Results for Denifanstat in Treating Moderate to Severe Acne

Sagimet Biosciences Is Maintained at Buy by Jones Trading

Sagimet Biosciences Inc : Jonestrading Raises Target Price to $27 From $15

THOMSON REUTERS

Promising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements

BUZZ-U.S. STOCKS ON THE MOVE-TransMedics, Centrus Energy, MongoDB

Sagimet Biosciences Shares Rise 7.2% After Oral Acne Drug With Partner Ascletis Met the Main Goals in a Late-Stage Trial

THOMSON REUTERS

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live

Private Payrolls Rise Less Than Expected in May, Stifling US Equity Futures Pre-Bell

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Trevi Therapeutics, Cactus, Copper miners

Sagimet Biosciences Shares Climb on Positive Clinical Trial Results for Acne Treatment

BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China

Sagimet Biosciences Shares Jump 52% Premarket After Oral Acne Drug With Partner Ascletis Met the Main Goals in a Late-Stage Trial

THOMSON REUTERS

Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat in Treating Moderate-to-Severe Acne

Sagimet Biosciences Inc - Denifanstat Meets All Primary and Secondary Endpoints in Phase 3 Trial

THOMSON REUTERS

Sagimet Biosciences Inc -Denifanstat Was Well Tolerated

THOMSON REUTERS

Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne From Partner Ascletis

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Janux Therapeutics Inc (JANX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SGMT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":9.83,"timestamp":1750795200000,"preClose":8.36,"halted":0,"volume":2839535,"hourTrading":{"tag":"盘后","latestPrice":9.85,"preClose":9.83,"latestTime":"19:56 EDT","volume":16675,"amount":163752.7107,"timestamp":1750809374842},"delay":0,"floatShares":23084506,"shares":32195345,"eps":-1.777054,"marketStatus":"Closed","change":1.47,"latestTime":"06-24 16:00:00 EDT","open":8.37,"high":10.425,"low":8.37,"amount":27531691.232075002,"amplitude":0.245813,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.777054,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750838400000},"marketStatusCode":5,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":8.36,"preHourTrading":{"tag":"盘前","latestPrice":8.5,"preClose":8.36,"latestTime":"09:28 EDT","volume":5040,"amount":42380.415,"timestamp":1750771699808},"postHourTrading":{"tag":"盘后","latestPrice":9.85,"preClose":9.83,"latestTime":"19:56 EDT","volume":16675,"amount":163752.7107,"timestamp":1750809374842},"volumeRatio":1.295549,"impliedVol":1.1905,"impliedVolPercentile":0.072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","floatShares":23084506,"roa":"-24.05%","roe":"-34.72%","lyrEps":-1.453459,"volumeRatio":1.295549,"shares":32195345,"dividePrice":0,"high":10.425,"amplitude":0.245813,"preClose":8.36,"low":8.37,"week52Low":1.73,"pbRate":"2.28","week52High":10.425,"institutionHeld":0,"latestPrice":9.83,"eps":-1.777054,"divideRate":0,"volume":2839535,"delay":0,"ttmEps":-1.777054,"open":8.37,"prevYearClose":4.5,"prevWeekClose":8.72,"prevMonthClose":3.55,"prevQuarterClose":3.26,"fiveDayClose":7.4,"twentyDayClose":3.45,"sixtyDayClose":3.76},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGMT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542232805","title":"Sagimet Biosciences Elects New Directors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542232805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542232805?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:51","pubTimestamp":1749592286,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A ( ($SGMT) ) has issued an announcement. On June 6, 2025, Sagimet Biosciences, Inc. amended executive employment a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-elects-new-directors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-elects-new-directors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2542328315","title":"Sagimet Biosciences Inc. Announces Revised Executive Compensation Agreements with Enhanced Severance Provisions","url":"https://stock-news.laohu8.com/highlight/detail?id=2542328315","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542328315?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:17","pubTimestamp":1749590279,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc. announced on June 6, 2025, the implementation of amended and restated executive employment agreements for its key executives, including CEO David Happel, CFO Thierry Chauche, and Dr. Eduardo Bruno Martins. The revised agreements introduce updated severance provisions to better align with market practices. Under the new terms, if Mr. Happel's employment is terminated without cause or if he resigns for good reason within 12 months following a change in control, he will be entitled to 24 months of his base salary, 24 months' worth of his target bonus, and a prorated target bonus for the current year. Additionally, if Mr. Happel opts for continued health coverage under COBRA, the company will cover both the employee and employer contributions for up to 24 months post-termination or until alternative group medical coverage is obtained. Furthermore, his stock options and other stock-based awards will fully vest immediately upon such termination. Similar terms apply t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL2Np3XY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2542891153","title":"Sagimet Biosciences to host KOL event on denifanstat results","url":"https://stock-news.laohu8.com/highlight/detail?id=2542891153","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542891153?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:16","pubTimestamp":1749467761,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) will host a virtual key opinion leader event on Monday, June 16, 2025 at 2:00 PM ET. The event will feature key opinion ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-to-host-kol-event-on-denifanstat-results-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-to-host-kol-event-on-denifanstat-results-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KOL","BK4139","SGMT"],"gpt_icon":0},{"id":"2542386405","title":"Sagimet Biosciences Announces Positive Phase 3 Trial Results for Denifanstat in Treating Moderate to Severe Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2542386405","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542386405?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:00","pubTimestamp":1749466857,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company, announced it will host a virtual key opinion leader  event on June 16, 2025, to discuss the positive results from a Phase 3 clinical trial of denifanstat, a novel treatment for moderate to severe acne vulgaris. The trial, conducted in China by Ascletis, Sagimet's license partner, demonstrated that denifanstat, a once-daily oral fatty acid synthase  inhibitor, met all primary and secondary endpoints versus placebo and was generally well tolerated. The event will feature insights from Neal Bhatia, MD, and include a live Q&A session. Additionally, Sagimet will discuss its newly initiated Phase 1 study for its second FASN inhibitor drug candidate, TVB-3567, intended for acne treatment in the U.S. A replay of the event will be available on Sagimet's website for 90 days post-event.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL6mMWyx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","BK4139","LU2210150020.SGD","SGMT","BK4585","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP","LU2095319765.USD"],"gpt_icon":0},{"id":"2541860625","title":"Sagimet Biosciences Is Maintained at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2541860625","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541860625?lang=en_us&edition=fundamental","pubTime":"2025-06-07 03:12","pubTimestamp":1749237120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 06, 2025 15:12 ET (19:12 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2541020357","title":"Sagimet Biosciences Inc : Jonestrading Raises Target Price to $27 From $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2541020357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541020357?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:03","pubTimestamp":1749125019,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S80ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2541010353","title":"Promising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2541010353","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541010353?lang=en_us&edition=fundamental","pubTime":"2025-06-05 12:28","pubTimestamp":1749097727,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Thomas Smith has reiterated their bullish stance on SGMT stock, giving a Buy rating yesterday. Thomas Smith has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-sagimet-biosciences-buy-rating-affirmed-by-positive-phase-3-trial-results-and-strategic-advancements-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-sagimet-biosciences-buy-rating-affirmed-by-positive-phase-3-trial-results-and-strategic-advancements-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT"],"gpt_icon":0},{"id":"2541093614","title":"BUZZ-U.S. STOCKS ON THE MOVE-TransMedics, Centrus Energy,  MongoDB","url":"https://stock-news.laohu8.com/highlight/detail?id=2541093614","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541093614?lang=en_us&edition=fundamental","pubTime":"2025-06-05 01:57","pubTimestamp":1749059857,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-TransMedics, Centrus Energy, MongoDBEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL3N3S719D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THO","ANVS","ON","TSYW.SI","MACW.SI","LU0528227936.USD","SCCO","DLTR","ANAB","LU0823421416.USD","OBT","SGMT","VNOM","TMDX","LU0075056555.USD","LU2097344357.USD","LU0719512351.SGD","LU2403377893.USD","MDB","SNOW","GFS","WHD","FLS","LU2326559502.SGD","YEXT","LVWR","TRVI","PC","VLO","ALB","BK4527","LU1206712785.SGD","BK4566","NXPI","IE00B19Z9Z06.USD","ASAN","LU0787776722.HKD","XOM","GTLS","FCX","LU0345770993.USD","FERG","BK4207","CVX"],"gpt_icon":1},{"id":"2540706916","title":"Sagimet Biosciences Shares Rise 7.2% After Oral Acne Drug With Partner Ascletis Met the Main Goals in a Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540706916","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540706916?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:33","pubTimestamp":1749044020,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S7084:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2540066705","title":"Sector Update: Health Care Stocks Mixed Premarket Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2540066705","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540066705?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:12","pubTimestamp":1749042742,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Wednesday as the iShares Biotechnology ETF  was 0.2% lower and the Health Care Select Sector SPDR Fund  was up 0.1% recently.Sagimet Biosciences  shares were rising by more than 14% after the company said denifanstat met primary and secondary endpoints in a phase 3 clinical trial to treat moderate to severe acne vulgaris.Merus  shares were down more than 7% after the company priced an underwritten public offering of about 5.3 million common shares at $57 per share for expected gross proceeds of about $300 million.AnaptysBio  shares were up more than 3% after the company reported updated interim results from its ongoing phase 2b trial of rosnilimab in patients with moderate-to-severe rheumatoid arthritis, showing that most participants improved after three months of treatment, with many maintaining those gains for at least two months after stopping therapy.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0889565916.HKD","BK4581","MRUS","LU0320765992.SGD","IBB","BK4588","ANAB","LU0109394709.USD","BK4139","XLV","SGMT"],"gpt_icon":0},{"id":"2540066770","title":"Private Payrolls Rise Less Than Expected in May, Stifling US Equity Futures Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2540066770","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540066770?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:11","pubTimestamp":1749042717,"startTime":"0","endTime":"0","summary":"US equity futures were little changed pre-bell Wednesday as traders digest labor market data.Dow Jones Industrial Average futures, S&P 500 futures, and Nasdaq futures were all down around 0.1%.Oil pri","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"73befb246a4592bd6ecd885dcf5848c0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","NVIW.SI","IE00B19Z8W00.USD","LU1974910355.USD","TSYW.SI","USJW.SI","SGMT","THO","QID","DOG","LU1712237335.SGD","LU2125909759.SGD","DDM","SQQQ","BK4588","LU0234570918.USD","QLD","LU2125909916.SGD","LU1201861249.SGD","TQQQ","MYMmain",".SPX","MNQmain","UDOW","BK4139","LU1917777945.USD","DXD","LU1861220033.SGD","SDOW","LU0648001328.SGD","USAW.SI","LU1720051108.HKD","LU1623119135.USD","EQR","LU2357305700.SGD","LU1989764748.USD","LU1169589451.USD","LU2023250504.SGD",".DJI","NQmain","LU1548497426.USD",".IXIC","BK4560","DJX","LU2265009873.SGD","PSQ","PANW","LU2106854487.HKD","BK4215"],"gpt_icon":1},{"id":"2540106804","title":"BUZZ-U.S. STOCKS ON THE MOVE-Trevi Therapeutics, Cactus, Copper miners","url":"https://stock-news.laohu8.com/highlight/detail?id=2540106804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540106804?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:38","pubTimestamp":1749037128,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Trevi Therapeutics, Cactus, Copper minersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL6N3S70JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2191332357.HKD","LU1506573853.SGD","HPE","LU0957791311.USD","LU1988902786.USD","TRVI","BHP.AU","LU1868836914.USD","FERG","FCX","LU0300736062.USD","HK0000320264.USD","LU1145028129.USD","LU2125909759.SGD","LU0109394709.USD","WHD","LU0234572021.USD","LU0345770308.USD","SGMT","LU2054465674.USD","LU0097036916.USD","LU1127390331.HKD","LU0345768740.USD","LU1989764664.SGD","SG9999014575.USD","LU0345769631.USD","LU0081259029.USD","IE00B3M56506.USD","LU1923622614.USD","MRUS","LU0320765059.SGD","LU2471134952.CNY","LU2592432038.USD","LU0494093205.USD","SCCO","LU2756315664.SGD","BK4139","LU1923621640.USD","LU0980610538.SGD","LU1037948541.HKD","MACW.SI","DLTR","JEMA.UK","RIO.UK","SG9999015986.USD","BK4551","LU2133065610.SGD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2540057224","title":"Sagimet Biosciences Shares Climb on Positive Clinical Trial Results for Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540057224","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540057224?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:44","pubTimestamp":1749033840,"startTime":"0","endTime":"0","summary":"Shares of Sagimet Biosciences rose after the company disclosed what it called positive results from a recent clinical trial of its treatment for moderate-to-severe acne.The stock jumped 42%, to $5.20, in pre-market trading Wednesday. Through Tuesday's close, shares have lost more than one-fifth of their value in the past year.The biopharmaceutical company before the bell said that its acne treatment, denifanstat, met all primary and secondary endpoints in a Phase 3 clinical trial in China.Denifanstat was generally well-tolerated by patients during the trial, with incidence rates of treatment-emergent adverse events comparable between the treatment and placebo, the company said.Chief Executive David Happel called the trial results highly encouraging, noting that the treatment represents a potentially novel approach to treat acne, one of the most prevalent skin diseases that physicians address annually.Sagimet additionally said it recently initiated a Phase 1 first-in-human clinical tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Sagimet Biosciences Shares Climb on Positive Clinical Trial Results for Acne Treatment","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1145","BK4139","00511","SGMT"],"gpt_icon":0},{"id":"2540055112","title":"BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2540055112","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540055112?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:27","pubTimestamp":1749029233,"startTime":"0","endTime":"0","summary":"BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China** Shares of drug developer Sagimet Biosciences SGMT.O rise 52% to $5.53 premarket** SGMT says its oral acne drug, denifanstat, met the main goals in a late-stage trial conducted by its Chinese partner Ascletis 1672.HK** Denifanstat showed 33.2% treatment success rate versus 14.6% for placebo** Denifanstat works by inhibiting the production of sebum, a key contributor to acne, through a novel mechanism of action, co says** The drug reduced total acne lesions by 57.4% compared to 35.4% with placebo** Ascletis plans to submit denifanstat for approval to Chinese regulators** As of last close, stock down 19.3% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL3N3S70LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK1574","BK1515","BK1161","BK4139","01672"],"gpt_icon":0},{"id":"2540055977","title":"Sagimet Biosciences Shares Jump 52% Premarket After Oral Acne Drug With Partner Ascletis Met the Main Goals in a Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540055977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540055977?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:15","pubTimestamp":1749028555,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01672","BK4139","BK1161","SGMT","BK1515"],"gpt_icon":0},{"id":"2540053848","title":"Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat in Treating Moderate-to-Severe Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2540053848","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540053848?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:00","pubTimestamp":1749027616,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, announced the positive results of a Phase 3 clinical trial conducted by its license partner, Ascletis Bioscience Co. Ltd. in China, for the treatment of moderate to severe acne vulgaris. The trial evaluated the oral small molecule fatty acid synthase  inhibitor, denifanstat, which met all primary and secondary endpoints versus a placebo and was well tolerated by participants. This development marks an advancement in acne treatment, introducing a novel mechanism of action through FASN inhibition. Additionally, Sagimet has initiated a Phase 1 clinical trial in the United States for a second FASN inhibitor, TVB-3567, targeting acne treatment. The positive outcomes from the trial underscore the potential of FASN inhibition as a therapeutic approach for acne.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9NgkYx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK1515","01672","BK4139","BK1161","BK4585","IE00BGHQF748.EUR","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","NDAQ","SGMT","LU2210149790.SGD","IE00B64PRP62.GBP","BK1574","BK4112","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2540675053","title":"Sagimet Biosciences Inc - Denifanstat Meets All Primary and Secondary Endpoints in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540675053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540675053?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:00","pubTimestamp":1749027600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA9XTCZG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2540605367","title":"Sagimet Biosciences Inc -Denifanstat Was Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2540605367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540605367?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:00","pubTimestamp":1749027600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA9XTCZG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2540505896","title":"Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne From Partner Ascletis","url":"https://stock-news.laohu8.com/highlight/detail?id=2540505896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540505896?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:00","pubTimestamp":1749027600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA9XTCZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2540255557","title":"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Janux Therapeutics Inc (JANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540255557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540255557?lang=en_us&edition=fundamental","pubTime":"2025-06-03 16:10","pubTimestamp":1748938230,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (PFE – Research Report), Sagimet Bioscience...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-sagimet-biosciences-inc-class-a-sgmt-and-janux-therapeutics-inc-janx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-sagimet-biosciences-inc-class-a-sgmt-and-janux-therapeutics-inc-janx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0321505868.SGD","SG9999002224.SGD","IE00B19Z3581.USD","SG9999003800.SGD","HCSG","SGMT","LU0985481810.HKD","SGXZ57979304.SGD","PFE","LU1066053197.SGD","IE000M9KFDE8.USD","LU0234572021.USD","JANX","LU0306806265.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4588","LU1894683348.USD","LU0225771236.USD","BK4539","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00BLSP4452.SGD","LU0306807586.USD","LU0058720904.USD","BK4592","BK4534","LU1066051498.USD","BK4550","LU0321505439.SGD","LU1057294990.SGD","LU0225284248.USD","SG9999011175.SGD","LU0868494617.USD","SG9999013999.USD","BK4568","BK4581","IE00BBT3K403.USD","LU0456855351.SGD","LU1894683264.USD","IE0002270589.USD","BK4599","IE00BLSP4239.USD","BK4137","LU0170899867.USD","SG9999002232.USD","BK4007","LU0122379950.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGMT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"SGMT","fiscalQuarterEnding":"2025/03","expectedEps":-0.79,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.56}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1738209600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGMT","date":"2025-06-23","current":-4.915492,"percent":0.398268,"low":-15.666506,"twenty":-6.564821,"median":-4.487819,"eighty":-3.076721,"high":-1.342444,"avg":-5.192594,"sd":2.832244,"marketCap":280743408},"quantilePoints":[{"date":"2023-07-21","current":-12.287206,"twenty":-13.337015,"median":-12.553129,"eighty":-11.625533,"marketCap":348354576},{"date":"2023-07-28","current":-12.208993,"twenty":-12.714826,"median":-12.49838,"eighty":-12.113574,"marketCap":346137170},{"date":"2023-08-04","current":-12.733018,"twenty":-12.595364,"median":-12.529665,"eighty":-12.271563,"marketCap":360993794},{"date":"2023-08-11","current":-12.514023,"twenty":-12.565643,"median":-12.517933,"eighty":-12.42486,"marketCap":354785056},{"date":"2023-08-18","current":-9.925184,"twenty":-12.565643,"median":-12.514023,"eighty":-12.265307,"marketCap":281388897},{"date":"2023-08-25","current":-9.359416,"twenty":-12.554693,"median":-12.471006,"eighty":-10.020915,"marketCap":262381858},{"date":"2023-09-01","current":-9.85717,"twenty":-12.553129,"median":-12.459274,"eighty":-9.809842,"marketCap":276335907},{"date":"2023-09-08","current":-10.126447,"twenty":-12.543743,"median":-12.279385,"eighty":-9.775571,"marketCap":283884818},{"date":"2023-09-15","current":-9.791891,"twenty":-12.532793,"median":-11.532454,"eighty":-9.775571,"marketCap":274505868},{"date":"2023-09-22","current":-8.282308,"twenty":-12.524972,"median":-10.126447,"eighty":-9.674388,"marketCap":232186213},{"date":"2023-09-29","current":-7.392878,"twenty":-12.517151,"median":-9.936056,"eighty":-9.403479,"marketCap":207251930},{"date":"2023-10-06","current":-5.866975,"twenty":-12.514023,"median":-9.90613,"eighty":-8.80291,"marketCap":164474765},{"date":"2023-10-13","current":-4.757227,"twenty":-12.495252,"median":-9.80821,"eighty":-7.764969,"marketCap":133364100},{"date":"2023-10-20","current":-3.729078,"twenty":-12.478045,"median":-9.791891,"eighty":-6.978354,"marketCap":104540984},{"date":"2023-10-27","current":-3.647479,"twenty":-12.474916,"median":-9.751091,"eighty":-6.462648,"marketCap":102253435},{"date":"2023-11-03","current":-3.100765,"twenty":-12.467095,"median":-9.681732,"eighty":-5.866975,"marketCap":86926858},{"date":"2023-11-10","current":-2.284775,"twenty":-12.467095,"median":-9.514454,"eighty":-4.757227,"marketCap":64051369},{"date":"2023-11-17","current":-1.981702,"twenty":-12.459274,"median":-9.396135,"eighty":-4.030995,"marketCap":53347428},{"date":"2023-11-24","current":-3.487116,"twenty":-12.32162,"median":-9.116089,"eighty":-3.455541,"marketCap":93873157},{"date":"2023-12-01","current":-3.248971,"twenty":-12.280949,"median":-8.665823,"eighty":-3.326797,"marketCap":87462307},{"date":"2023-12-08","current":-3.436085,"twenty":-12.223071,"median":-7.870232,"eighty":-3.326797,"marketCap":92499403},{"date":"2023-12-15","current":-4.74588,"twenty":-11.827315,"median":-7.466317,"eighty":-3.305106,"marketCap":127759077},{"date":"2023-12-22","current":-4.79691,"twenty":-11.412789,"median":-6.927763,"eighty":-3.326797,"marketCap":129132830},{"date":"2023-12-29","current":-5.009539,"twenty":-10.856914,"median":-6.462648,"eighty":-3.351567,"marketCap":134856803},{"date":"2024-01-05","current":-4.286601,"twenty":-10.142767,"median":-6.27497,"eighty":-3.385054,"marketCap":115395295},{"date":"2024-01-12","current":-6.055674,"twenty":-10.126447,"median":-6.038333,"eighty":-3.402064,"marketCap":163018751},{"date":"2024-01-19","current":-5.494334,"twenty":-10.061168,"median":-5.928097,"eighty":-3.422477,"marketCap":147907462},{"date":"2024-01-26","current":-11.924235,"twenty":-11.412789,"median":-6.047003,"eighty":-3.434384,"marketCap":321000405},{"date":"2024-02-02","current":-11.8484,"twenty":-11.755197,"median":-6.332089,"eighty":-3.449693,"marketCap":318958920},{"date":"2024-02-09","current":-7.10904,"twenty":-11.755197,"median":-6.72671,"eighty":-3.480312,"marketCap":191375352},{"date":"2024-02-16","current":-10.260714,"twenty":-11.412789,"median":-7.18072,"eighty":-3.487116,"marketCap":276218424},{"date":"2024-02-23","current":-7.973973,"twenty":-11.272575,"median":-7.393401,"eighty":-3.512632,"marketCap":214659353},{"date":"2024-03-01","current":-7.263069,"twenty":-10.976358,"median":-7.495026,"eighty":-3.600344,"marketCap":195521817},{"date":"2024-03-08","current":-7.642218,"twenty":-10.478725,"median":-7.466317,"eighty":-3.696438,"marketCap":205728503},{"date":"2024-03-15","current":-5.118509,"twenty":-10.189946,"median":-7.39314,"eighty":-3.910228,"marketCap":137790253},{"date":"2024-03-22","current":-5.509506,"twenty":-10.132975,"median":-7.18072,"eighty":-4.056781,"marketCap":148315897},{"date":"2024-03-28","current":-6.56,"twenty":-10.093807,"median":-7.132737,"eighty":-4.084178,"marketCap":182866572},{"date":"2024-04-05","current":-6.239442,"twenty":-10.00568,"median":-6.795721,"eighty":-4.174333,"marketCap":173930684},{"date":"2024-04-12","current":-5.976126,"twenty":-9.938231,"median":-6.56,"eighty":-4.313817,"marketCap":166590490},{"date":"2024-04-19","current":-4.545061,"twenty":-9.925184,"median":-6.397368,"eighty":-4.392065,"marketCap":126698131},{"date":"2024-04-26","current":-4.487819,"twenty":-9.917562,"median":-6.217851,"eighty":-4.458405,"marketCap":125102437},{"date":"2024-05-03","current":-5.09459,"twenty":-9.886546,"median":-6.182199,"eighty":-4.468439,"marketCap":142016797},{"date":"2024-05-10","current":-5.231972,"twenty":-9.844114,"median":-6.079163,"eighty":-4.479356,"marketCap":145846463},{"date":"2024-05-17","current":-5.429865,"twenty":-9.811474,"median":-6.018678,"eighty":-4.487871,"marketCap":151590963},{"date":"2024-05-24","current":-5.372708,"twenty":-9.791891,"median":-5.987575,"eighty":-4.491214,"marketCap":149995268},{"date":"2024-05-31","current":-6.172899,"twenty":-9.791891,"median":-5.987575,"eighty":-4.501006,"marketCap":172334989},{"date":"2024-06-07","current":-5.315552,"twenty":-9.783731,"median":-5.976126,"eighty":-4.523122,"marketCap":148399574},{"date":"2024-06-14","current":-5.47559,"twenty":-9.751091,"median":-5.952111,"eighty":-4.533251,"marketCap":152867518},{"date":"2024-06-21","current":-4.446773,"twenty":-9.731508,"median":-5.91688,"eighty":-4.519544,"marketCap":124145020},{"date":"2024-06-28","current":-4.698262,"twenty":-9.718452,"median":-5.91688,"eighty":-4.523122,"marketCap":131166075},{"date":"2024-07-05","current":-3.257919,"twenty":-9.685812,"median":-5.888477,"eighty":-4.48795,"marketCap":90954577},{"date":"2024-07-12","current":-3.738033,"twenty":-9.677652,"median":-5.800519,"eighty":-4.448199,"marketCap":104358410},{"date":"2024-07-15","current":-3.806621,"twenty":-9.67602,"median":-5.796735,"eighty":-4.447058,"marketCap":106273243},{"date":"2024-08-02","current":-3.97809,"twenty":-9.674388,"median":-5.79295,"eighty":-4.391494,"marketCap":111060326},{"date":"2024-08-09","current":-3.109312,"twenty":-9.635837,"median":-5.632964,"eighty":-4.048186,"marketCap":86805772},{"date":"2024-08-16","current":-3.011259,"twenty":-9.556995,"median":-5.529634,"eighty":-3.765468,"marketCap":88082328},{"date":"2024-08-23","current":-3.174914,"twenty":-9.5049,"median":-5.509506,"eighty":-3.626007,"marketCap":92869411},{"date":"2024-08-30","current":-3.36039,"twenty":-9.480538,"median":-5.47559,"eighty":-3.517501,"marketCap":98294771},{"date":"2024-09-06","current":-2.913065,"twenty":-9.458966,"median":-5.429865,"eighty":-3.459899,"marketCap":85210078},{"date":"2024-09-13","current":-3.709522,"twenty":-9.418167,"median":-5.410329,"eighty":-3.440029,"marketCap":108507215},{"date":"2024-09-20","current":-3.578597,"twenty":-9.3382,"median":-5.372708,"eighty":-3.459899,"marketCap":104677549},{"date":"2024-09-27","current":-3.076721,"twenty":-9.217671,"median":-5.306102,"eighty":-3.426198,"marketCap":89997161},{"date":"2024-10-04","current":-4.495067,"twenty":-9.063099,"median":-5.281258,"eighty":-3.402458,"marketCap":131485214},{"date":"2024-10-11","current":-4.516888,"twenty":-9.008144,"median":-5.226248,"eighty":-3.408396,"marketCap":132123492},{"date":"2024-10-18","current":-5.891593,"twenty":-8.972181,"median":-5.273199,"eighty":-3.426198,"marketCap":172334989},{"date":"2024-10-25","current":-6.000697,"twenty":-8.935294,"median":-5.292689,"eighty":-3.429281,"marketCap":175526378},{"date":"2024-10-31","current":-5.826131,"twenty":-8.894301,"median":-5.311818,"eighty":-3.436085,"marketCap":170420156},{"date":"2024-11-08","current":-6.753511,"twenty":-8.791513,"median":-5.372708,"eighty":-3.436763,"marketCap":197546960},{"date":"2024-11-15","current":-5.651565,"twenty":-8.755967,"median":-5.41811,"eighty":-3.453095,"marketCap":165313934},{"date":"2024-11-22","current":-3.861691,"twenty":-8.665823,"median":-5.372708,"eighty":-3.487116,"marketCap":144879052},{"date":"2024-11-29","current":-4.882893,"twenty":-8.557843,"median":-5.315552,"eighty":-3.487116,"marketCap":183191513},{"date":"2024-12-06","current":-3.998995,"twenty":-8.332016,"median":-5.292689,"eighty":-3.504949,"marketCap":150030307},{"date":"2024-12-13","current":-3.896017,"twenty":-8.272608,"median":-5.273199,"eighty":-3.525595,"marketCap":146166866},{"date":"2024-12-20","current":-4.350838,"twenty":-8.042693,"median":-5.190447,"eighty":-3.550034,"marketCap":163230399},{"date":"2024-12-27","current":-4.35942,"twenty":-7.978712,"median":-5.107971,"eighty":-3.56885,"marketCap":163552352},{"date":"2025-01-03","current":-3.853109,"twenty":-7.96022,"median":-5.094591,"eighty":-3.578236,"marketCap":144557099},{"date":"2025-01-10","current":-4.608284,"twenty":-7.932249,"median":-5.088866,"eighty":-3.585335,"marketCap":172889002},{"date":"2025-01-17","current":-3.664315,"twenty":-7.891035,"median":-5.014451,"eighty":-3.578519,"marketCap":137474123},{"date":"2025-01-24","current":-3.561337,"twenty":-7.843641,"median":-5.001034,"eighty":-3.577995,"marketCap":133610681},{"date":"2025-01-31","current":-3.484103,"twenty":-7.800873,"median":-4.931489,"eighty":-3.565628,"marketCap":130713100},{"date":"2025-02-07","current":-4.041903,"twenty":-7.796247,"median":-4.899965,"eighty":-3.577995,"marketCap":151640074},{"date":"2025-02-14","current":-3.775875,"twenty":-7.711114,"median":-4.882893,"eighty":-3.5785,"marketCap":141659518},{"date":"2025-02-21","current":-3.454068,"twenty":-7.655997,"median":-4.848447,"eighty":-3.56477,"marketCap":129586263},{"date":"2025-02-28","current":-3.097934,"twenty":-7.585345,"median":-4.824006,"eighty":-3.534402,"marketCap":116225195},{"date":"2025-03-07","current":-3.13226,"twenty":-7.533213,"median":-4.786117,"eighty":-3.487116,"marketCap":117513009},{"date":"2025-03-14","current":-2.479989,"twenty":-7.4778,"median":-4.774032,"eighty":-3.471231,"marketCap":113005660},{"date":"2025-03-21","current":-2.861526,"twenty":-7.417463,"median":-4.751553,"eighty":-3.434384,"marketCap":130391147},{"date":"2025-03-28","current":-2.656626,"twenty":-7.395771,"median":-4.728869,"eighty":-3.400275,"marketCap":121054497},{"date":"2025-04-04","current":-1.603868,"twenty":-7.392983,"median":-4.702859,"eighty":-3.36039,"marketCap":73083433},{"date":"2025-04-11","current":-1.575606,"twenty":-7.289031,"median":-4.694849,"eighty":-3.31696,"marketCap":71795619},{"date":"2025-04-17","current":-1.42723,"twenty":-7.21366,"median":-4.648098,"eighty":-3.301626,"marketCap":65034596},{"date":"2025-04-25","current":-2.204435,"twenty":-7.173257,"median":-4.603993,"eighty":-3.254074,"marketCap":100449476},{"date":"2025-05-02","current":-2.77674,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"marketCap":126527705},{"date":"2025-05-09","current":-1.80385,"twenty":-7.118519,"median":-4.541885,"eighty":-3.18279,"marketCap":103025104},{"date":"2025-05-16","current":-1.865858,"twenty":-6.931314,"median":-4.533251,"eighty":-3.143037,"marketCap":106566591},{"date":"2025-05-23","current":-1.922228,"twenty":-6.7923,"median":-4.516125,"eighty":-3.120362,"marketCap":109786126},{"date":"2025-05-30","current":-1.972961,"twenty":-6.768572,"median":-4.505306,"eighty":-3.099066,"marketCap":112683707},{"date":"2025-06-06","current":-2.694501,"twenty":-6.722029,"median":-4.495067,"eighty":-3.076721,"marketCap":153893749},{"date":"2025-06-13","current":-4.853485,"twenty":-6.632098,"median":-4.487884,"eighty":-3.076721,"marketCap":277201920},{"date":"2025-06-20","current":-3.968471,"twenty":-6.566428,"median":-4.480766,"eighty":-3.076721,"marketCap":226655228},{"date":"2025-06-23","current":-4.915492,"twenty":-6.564821,"median":-4.487819,"eighty":-3.076721,"marketCap":280743408}],"updateTime":1750771752225}}}